Pragati Silakari

Inhibitors of Microsomal Prostaglandin E2 Synthase‐1 Enzyme as Emerging Anti‐Inflammatory Candidates

O. Silakari, M. Singh Bahia, Yogesh Kumar Katare, 2014, Medicinal research reviews.

Design, synthesis and pharmacological evaluation of some novel indanone derivatives as acetylcholinesterase inhibitors for the management of cognitive dysfunction.

Anjali, Anuradha Sharma, P. Piplani, 2018, Bioorganic & medicinal chemistry.

p-Benzoquinone a privileged scaffold of pharmacological significance: A review.

P. Piplani, Pragati Silakari, P. Chhikara, 2020, Mini reviews in medicinal chemistry.

Purinergic receptor P2X₇: a novel target for anti-inflammatory therapy.

Manjinder Singh, M. S. Bahia, O. Silakari, 2014, Bioorganic & medicinal chemistry.

Interleukin-1 receptor associated kinase inhibitors: potential therapeutic agents for inflammatory- and immune-related disorders.

M. S. Bahia, O. Silakari, M. Kaur, 2015, Cellular signalling.

Systematic In Silico Design, Synthesis, and Biological Studies of Some Novel 1,4-Benzoquinone Derivatives for the Prospective Management of Cognitive Decline.

O. Silakari, P. Piplani, Pragati Silakari, 2021, ACS chemical neuroscience.

Pyridazinones: A versatile scaffold in the development of potential target based novel anticancer agents

Pragati Silakari, Sandeep Kumar, Jyoti Singh, 2022, Journal of Heterocyclic Chemistry.